859217-85-9

Basic information

• Product Name: 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl)
• Synonyms: 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl);4,4,5,5-TetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl)-1,3,2-dioxaborolane;4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethylcyclohex-1-enyl)-1,3,2-dioxaborolane;4,4,5,5-TetraMethyl-2-(3,3,5,5-tetraMethylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane;3,3,5,5-Tetramethyl-1-cyclohexen-1-ylboronic acid pinacol ester;4,4,5,5-Tetramethyl-2-(3,3,5,5-tetramethylcyclohex-1-en-1-yl);3,3,5,5-Tetramethyl-Cyclohexene-1-boronic acid pinacol ester;(3,3,5,5-TETRAMETHYLCYCLOHEX-1-EN-1-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 859217-85-9
• Molecular Formula: C₁₆H₂₉BO₂
• Molecular Weight: 264.21126
• Mol File: 859217-85-9.mol

Chemical Properties

• Boiling Point: 277.6±33.0℃ (760 Torr)
• Flash Point: 121.7±25.4℃
• Appearance: Yellow solid
• Density: 0.93±0.1 g/cm3 (20 ºC 760 Torr)
• Vapor Pressure: 0.00757mmHg at 25°C
• Refractive Index: 1.466
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl)(859217-85-9)
• EPA Substance Registry System: 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl)(859217-85-9)

Safety Data

• Hazardous Substances Data: 859217-85-9(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl) is used as a reagent in organic synthesis for the preparation of various functionalized molecules. Its unique structure and reactivity enable it to participate in various reactions, including cross-coupling reactions and Suzuki-Miyaura coupling reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl) is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its ability to participate in cross-coupling reactions and Suzuki-Miyaura coupling reactions allows for the efficient production of complex molecules with potential therapeutic applications.
Used in Agrochemical Industry:
1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl) is also used in the agrochemical industry for the synthesis of various agrochemical compounds. Its reactivity in cross-coupling reactions and Suzuki-Miyaura coupling reactions contributes to the development of new and effective agrochemicals for crop protection and pest control.
Used in Materials Science:
In the field of materials science, 1,3,2-Dioxaborolane, 4,4,5,5-tetraMethyl-2-(3,3,5,5-tetraMethyl-1-cyclohexen-1-yl) is utilized for the synthesis of functional materials with specific properties. Its unique reactivity allows for the creation of novel materials with potential applications in various industries, such as electronics, energy, and environmental protection.

InChI:InChI=1/C16H29BO2/c1-13(2)9-12(10-14(3,4)11-13)17-18-15(5,6)16(7,8)19-17/h9H,10-11H2,1-8H3

Upstream product

• 61676-62-8 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 42449-09-2 3.3.5.5-Tetramethylcyclohexanon-p-tosylhydrazon 
• 86544-77-6 3,3,5,5-tetramethylcyclohex-1-enyl trifluoromethanesulfonate 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 32939-21-2 3,3,5,5-tetramethylcyclohex-1-ene-1-carboxylic acid 

Relevant articles and documents

Convenient preparation of cycloalkenyl boronic acid pinacol esters

A practical method for the preparation of cycloalkenyl boronic acid pinacol esters is described. These important synthetic intermediates are typically made using more expensive methods like transition metal-catalyzed borylation of alkenyl halides or trifl

7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE

The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof, the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and the use in medicine and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them

1,2-Di(cyclic)substituted benzene compounds

In one aspect, the present invention provides compounds having formula (1) or (100), a salt thereof or a hydrate of the foregoing, which compounds exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome; rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.